UBS AM’s EMULEX CORP ELX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-45,796
Closed -$365K 2759
2015
Q1
$365K Buy
45,796
+1,900
+4% +$13.3K ﹤0.01% 2142
2014
Q4
$249K Buy
43,896
+6,800
+18% +$36.6K ﹤0.01% 2348
2014
Q3
$183K Hold
37,096
﹤0.01% 2407
2014
Q2
$211K Buy
37,096
+2,400
+7% +$14.3K ﹤0.01% 2387
2014
Q1
$256K Hold
34,696
﹤0.01% 2281
2013
Q4
$248K Sell
34,696
-5,400
-13% -$40.1K ﹤0.01% 2261
2013
Q3
$311K Hold
40,096
﹤0.01% 2062
2013
Q2
$261K Buy
+40,096
New +$252K ﹤0.01% 2087

UBS AM's ELX Position: Q2 2015 in Review

UBS AM sold out of EMULEX CORP (ELX) in Q2 2015, closing a stake of 45,796 shares — an estimated $365K sold.

UBS AM first reported a position in ELX in Q2 2013 and held it in 8 quarters. The position peaked at $365K in Q1 2015. 0 funds tracked by Wall St. Rank hold ELX as of Q2 2015.

  • UBS AM reported no remaining EMULEX CORP position as of Q2 2015 after selling out during the quarter.
  • UBS AM sold 45,796 EMULEX CORP shares in Q2 2015, an estimated $365K.
  • UBS AM first reported a position in EMULEX CORP in Q2 2013 and held it in 8 quarters.
  • UBS AM's EMULEX CORP position peaked at $365K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held EMULEX CORP as of Q2 2015.

Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.